AW
COLL icon

Ankerstar Wealth’s Collegium Pharmaceutical COLL Stock Holding History

Ankerstar Wealth’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290 Hold
8
– – ﹤0.01% 810
2026
Q1 		$265 Hold
8
– – ﹤0.01% 795
2025
Q4 		$370 Buy
+8
New +$335 ﹤0.01% 737

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Ankerstar Wealth's COLL Position: Q2 2026 in Review

Ankerstar Wealth held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 8 shares worth $290. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Ankerstar Wealth first reported a position in COLL in Q4 2025 and has held it in 3 quarters since. The position peaked at $370 in Q4 2025. 277 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Ankerstar Wealth held 8 shares of Collegium Pharmaceutical worth $290 as of Q2 2026.
  • Ankerstar Wealth left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Ankerstar Wealth's portfolio in Q2 2026, its #810 holding.
  • Ankerstar Wealth first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Ankerstar Wealth's Collegium Pharmaceutical position peaked at $370 in Q4 2025.
  • 277 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Ankerstar Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.